[Leish-l] GLUCANTIME price reduction
Jeffrey Shaw
jayusp at gmail.com
Mon May 21 16:25:42 BRT 2007
Dear colleagues,
We have the pleasure to share with you that* sanofi-Aventis* has announced
offically WHO with the reduction of a "no-profit, no-loss" price of
GLUCANTIME to * US**$ 1,20 per vial + customs taxes + distribution cost* to
Public Sector Agencies of all Developing Countries, for the treatment of* **
leishmaniasis*. This important achievement will have enormous impact in many
regions in the control of this neglected tropical disease.
The reduction is effective from now. Interested can enter in contact
directly with sanofi-Aventis commercials in each country. If you have any
question, contact WHO, please.
Please, circulate this important information.
Yours sincerely,
Dr Jorge Alvar
Medical Officer (Leishmaniasis Control)
*Control of Neglected Tropical Diseases*
Innovative and Intensified Disease Management
Communicable Diseases Cluster
*World Health Organization*
20, Avenue Appia; CH-1211 Geneva 27
Tel. +41 22 791 3870
Fax +41 22 791 4877
e-mail: alvarj at who.int
-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lineu.icb.usp.br/pipermail/leish-l/attachments/20070521/48f9bc04/attachment.htm
More information about the Leish-l
mailing list